Antoni Ribas, MD, PhD: For certain cancers where we know it can only work in a specific situation that has a specific marker, having a companion diagnostic makes a lot of sense. You want to select ...

Many U.S. hospitals using predictive models are not evaluating their tools internally for accuracy, and fewer still are evaluating them for potential biases, according to a study published in the most ...

Traditional testing, though valuable, is often reactive and identifies quality issues only after they have occurred. This can lead to project delays and financial and reputational losses. In fact, ...

Add Yahoo as a preferred source to see more of our stories on Google. MiraDx's Prostox Standard test aims to identify localised prostate cancer patients who may experience long-term California-based ...

Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

AI has become an increasingly hot technology for the healthcare sector, boosting venture capital investment and spurring interest in tools that could stretch the overburdened provider workforce. But ...

RICHMOND, VA, and PITTSBURGH, April 25, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Wako Chemicals U.S.A. Corporation (Fujifilm), a supplier of high purity chemicals and reagents, and Predictive Oncology Inc., ...